lung-cancer

Documents about lung-cancer

• T-Cell PET Imaging With [18F]F-AraG in Lung Cancer#300241ClinicalTrials.gov
• T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer#321689ClinicalTrials.gov
• AMT-116 in Combination With Ivosidan in Patients With Lung Cancer#356471ClinicalTrials.gov
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer#366616ClinicalTrials.gov
• Veteran and Lung Cancer Screening Coordinator Perspectives on Improving Adherence to Lung Cancer Screening.#427970NCBI PubMed Central
• Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile#171651HAL (France)
• Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer#405142ClinicalTrials.gov
• Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy#160339ClinicalTrials.gov
• ProCaLung: Project on Cancer of the Lung#387163ClinicalTrials.gov
• Cancer statistics, 2022#6834OpenAlex
• Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study#67872ClinicalTrials.gov
• Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer#148762ClinicalTrials.gov
• Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy#143555ClinicalTrials.gov
• LIFE - Lung Cancer, Immunotherapy, Frailty, Effect#146440ClinicalTrials.gov
• Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients#162472ClinicalTrials.gov
• Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study#217011ClinicalTrials.gov
• Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer#307450ClinicalTrials.gov
• FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer#321682ClinicalTrials.gov
• Deep learning mutli-omics integration identifes new subtypes of lung cancer#348775RUcore, Rutgers University Community Repository
• Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer#377406ClinicalTrials.gov
• The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension#417461ClinicalTrials.gov
• Electro-Acupuncture in Lung cancER : EALER Study#435748ClinicalTrials.gov
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)#201767ClinicalTrials.gov
• Cancer statistics, 2012#6915OpenAlex
• Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer#143782ClinicalTrials.gov
• Adaptive Symptom Self-Management Immunotherapy Study#18578ClinicalTrials.gov
• Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients#121369ClinicalTrials.gov
• Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer#300248ClinicalTrials.gov
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients#158199ClinicalTrials.gov
• Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)#136324ClinicalTrials.gov
• CIETAI and Sequential Radiotherapy in Squamous Lung Cancer#249602ClinicalTrials.gov
• Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy#195324ClinicalTrials.gov
• A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.#201621ClinicalTrials.gov
• Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance#226281ClinicalTrials.gov
• Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels#272345ClinicalTrials.gov
• A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer#346916ClinicalTrials.gov
• Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)#417556ClinicalTrials.gov
• Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer#417558ClinicalTrials.gov
• HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer#346976ClinicalTrials.gov
• Global Cancer Statistics, 2002#6833OpenAlex
• Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer#394619ClinicalTrials.gov
• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)#127580ClinicalTrials.gov
• Program-Based Lung Cancer Care: A Prospective Observational Tumor Registry Linkage Study#20029DOAJ
• PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer#253003ClinicalTrials.gov
• Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer#67905ClinicalTrials.gov
• PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer#127586ClinicalTrials.gov
• Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification#262070HAL (France)
• Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer—Spanish Lung Cancer Group Expert Consensus Statement.#266843NCBI PubMed Central
• Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker#398306ClinicalTrials.gov
• Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)#398324ClinicalTrials.gov